Differential effects of teriparatide and alendronate on bone parameters in postmenopausal women with osteoporosis

被引：0
|
作者：
McClung, MR
Martin, JS
Meunier, PJ
Miller, PD
Haddock, L
Bandeira, F
Szejnfled, V
Donley, DW
Eriksen, EF
机构：
[1] Oregon Osteoporosis Ctr, Portland, OR USA
[2] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
[3] Fac Med R Laennec, INSERM, U403, Lyon, France
[4] Fac Med R Laennec, Lab Histodynam Osseuse, Lyon, France
[5] Colorado Ctr Bone Res, Lakewood, CO USA
[6] Hosp Agamenon Magalhaes, Recife, PE, Brazil
[7] Escola Paulista Med, BR-04023 Sao Paulo, Brazil
来源：
OSTEOPOROSIS INTERNATIONAL | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S5 / S5
页数：1
相关论文
共 50 条
  • [21] Effects of Teriparatide in Postmenopausal Women with Osteoporosis on Prior Alendronate or Raloxifene: Differences between Stopping and Continuing the Antiresorptive Agent
    Cosman, Felicia
    Wermers, Robert A.
    Recknor, Christopher
    Mauck, Karen F.
    Xie, Li
    Glass, Emmett V.
    Krege, John H.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (10): : 3772 - 3780
  • [22] Teriparatide Reduces Bone Microdamage Accumulation in Postmenopausal Women Previously Treated With Alendronate
    Dobnig, Harald
    Stepan, Jan J.
    Burr, David B.
    Li, Jiliang
    Michalska, Dana
    Sipos, Adrien
    Petto, Helmut
    Fahrleitner-Pammer, Astrid
    Pavo, Imre
    JOURNAL OF BONE AND MINERAL RESEARCH, 2009, 24 (12) : 1998 - 2006
  • [23] Teriparatide reduces bone microdamage accumulation in postmenopausal women previously treated with alendronate
    Dobnig, H.
    Stepan, J. J.
    Burr, D. B.
    Fahrleitner-Pammer, A. F.
    Li, J.
    Sipos, A.
    Sato, M.
    Pavo, I.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S28 - S28
  • [24] Evaluation of bone remodelling parameters after one year treatment with alendronate in postmenopausal women with osteoporosis
    Kucukalic-Selimovic, Elma
    Valjevac, Amina
    Hadzovic-Dzuvo, Almira
    Skopljak-Beganovic, Amra
    Alimanovic-Alagic, Rubina
    Brkovic, Amera
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2011, 11 (01) : 41 - 45
  • [25] PROGRESSIVENESS AND GENERALIZABILITY OF THE EFFECTS OF ALENDRONATE ON BONE MASS AND SAFETY EXPERIENCE IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    EMKEY, R
    CORREAROTTER, R
    SANTORA, A
    LOMBARDI, A
    DAIFOTIS, A
    ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 1239 - 1239
  • [26] Factors associated with bone response to teriparatide in young postmenopausal women with osteoporosis
    Anna, Gosset
    Anne-Lise, Farcy
    Clemence, Dufond
    Jean-Michel, Pouilles
    Florence, Tremollieres
    JOURNAL OF BONE AND MINERAL METABOLISM, 2023, 41 (2) : 278 - 285
  • [27] Factors associated with bone response to teriparatide in young postmenopausal women with osteoporosis
    Gosset Anna
    Farcy Anne-Lise
    Dufond Clémence
    Pouillès Jean-Michel
    Trémollieres Florence
    Journal of Bone and Mineral Metabolism, 2023, 41 : 278 - 285
  • [28] Response rate of bone mineral density to teriparatide in postmenopausal women with osteoporosis
    Gallagher, J. C.
    Rosen, C. J.
    Chen, P.
    Misurski, D. A.
    Marcus, R.
    BONE, 2006, 39 (06) : 1268 - 1275
  • [29] The effects of teriparatide on the incidence of back pain in postmenopausal women with osteoporosis
    Genant, HK
    Halse, J
    Briney, WG
    Xie, L
    Glass, EV
    Krege, JH
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (07) : 1027 - 1034
  • [30] Effects of alendronate and risedronate on bone mineral density and bone turnover markers in late postmenopausal women with osteoporosis
    Aysegul Atmaca
    Olcay Gedik
    Advances in Therapy, 2006, 23 : 842 - 853
12345